Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hou, F. F.
Right arrow Articles by Zhang, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hou, F. F.
Right arrow Articles by Zhang, X.
J Am Soc Nephrol 15:1889-1896, 2004
© 2004 American Society of Nephrology


CLINICAL SCIENCE

Enhanced Expression of Receptor for Advanced Glycation End Products in Chronic Kidney Disease

Fan Fan Hou*, Hao Ren*, William F. Owen, Jr{dagger}, Zhi Jian Guo*, Ping Yan Chen*, Ann Marie Schmidt{ddagger}, Toshio Miyata§ and Xun Zhang*

*Division of Nephrology, Nanfang Hospital, Guangzhou, People’s Republic of China; {dagger}Department of Medicine, Duke University Medical Center, Durham, North Carolina; {ddagger}Department of Surgery, Columbia University, College of Physicians and Surgeons, New York, New York; §Molecular and Cellular Nephrology, Institute of Medical Sciences, Tokai University School of Medicine, Isehara, Japan; and Baxter Healthcare Corporation, Waukegan, Illinois.

Correspondence to Dr. Fan Fan Hou, Division of Nephrology, Nanfang Hospital, Guangzhou 510515, PR China. Phone: 86-20-61641591; Fax: 86-20-87281713; E-mail: ffhou{at}public.guangzhou.gd.cn

ABSTRACT. Inappropriate chronic inflammation associated with progressive, chronic kidney disease (CKD) reflects sustained activation of immunocompetent cells, like monocytes/macrophages. Advanced glycation end products (AGE) accumulate in CKD, but it is unclear if they stimulate monocytes by binding with the receptor for AGE (RAGE). Posited was the notion that RAGE plays a contributory role to monocyte-mediated systemic inflammation of progressive CKD. Peripheral blood monocytes were isolated from 102 patients without diabetes with varying severity of CKD. RAGE expression on peripheral blood monocytes increased with worsening CKD (r2 = 0.73) and was strongly correlated with plasma levels of pentosidine, a marker for AGE (r = 0.71). Strongly positive statistical correlations were observed in patients with CKD between monocyte RAGE and plasma levels of tumor necrosis factor alpha (TNF-{alpha}) (r = 0.61), the monocyte activation marker, neopterin (r = 0.65), and the systemic acute phase reactant, C-reactive protein (r = 0.44). Monocytes obtained from patients with CKD showed a monotonic increase in the number and affinity of specific AGE binding sites and increased production of TNF-{alpha} under stimulation of AGE. All these upregulatory responses in uremic monocytes could be largely blocked by an anti-RAGE antibody. It was concluded that RAGE expression was upregulated on monocytes from patients with CKD. Enhanced RAGE may amplify AGE-induced monocytes perturbation and contribute to monocyte-mediated systemic inflammation in progressive CKD.




This article has been cited by other articles:


Home page
Ann Clin BiochemHome page
L. F Brown and C. G Fraser
Assay validation and biological variation of serum receptor for advanced glycation end-products
Ann Clin Biochem, September 1, 2008; 45(5): 518 - 519.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Zen, C. X.-J. Chen, Y.-T. Chen, R. Wilton, and Y. Liu
Receptor for Advanced Glycation Endproducts Mediates Neutrophil Migration across Intestinal Epithelium
J. Immunol., February 15, 2007; 178(4): 2483 - 2490.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. M. Vincent, L. Perrone, K. A. Sullivan, C. Backus, A. M. Sastry, C. Lastoskie, and E. L. Feldman
Receptor for Advanced Glycation End Products Activation Injures Primary Sensory Neurons via Oxidative Stress
Endocrinology, February 1, 2007; 148(2): 548 - 558.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. A. Verkade, C. J. van Druningen, L. M. B. Vaessen, D. A. Hesselink, W. Weimar, and M. G. H. Betjes
Functional impairment of monocyte-derived dendritic cells in patients with severe chronic kidney disease
Nephrol. Dial. Transplant., January 1, 2007; 22(1): 128 - 138.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. X. Liu, F. F. Hou, Z. J. Guo, R. Nagai, W. R. Zhang, Z. Q. Liu, Z. M. Zhou, M. Zhou, D. Xie, G. B. Wang, et al.
Advanced Oxidation Protein Products Accelerate Atherosclerosis Through Promoting Oxidative Stress and Inflammation
Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1156 - 1162.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
F. Stam, C. G. Schalkwijk, C. van Guldener, P. M. ter Wee, and C. D. A. Stehouwer
Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals
Nephrol. Dial. Transplant., March 1, 2006; 21(3): 677 - 682.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. R. Chade, A. Lerman, and L. O. Lerman
Kidney in Early Atherosclerosis
Hypertension, June 1, 2005; 45(6): 1042 - 1049.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP